{"id":17239,"date":"2020-05-14T14:58:00","date_gmt":"2020-05-14T12:58:00","guid":{"rendered":"https:\/\/www.hollandbio.nl\/?p=17239"},"modified":"2020-05-19T15:00:11","modified_gmt":"2020-05-19T13:00:11","slug":"intravacc-to-develop-emergency-and-conventional-covid-19-vaccines","status":"publish","type":"post","link":"https:\/\/www.hollandbio.nl\/en\/nieuws\/intravacc-to-develop-emergency-and-conventional-covid-19-vaccines\/","title":{"rendered":"Intravacc to develop emergency and conventional COVID-19 vaccines"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\"><strong>Intravacc, one of the leading\ntranslational research and development vaccine institutes with an extensive\ntrack record in developing viral and bacterial&nbsp; vaccines,&nbsp; today\nannounced the&nbsp; development of three COVID-19 vaccine concepts. These\nconcepts are all based on Intravacc\u2019s platform technologies, that have been\nproven safe in humans.<\/strong><strong><\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><em>\u201cThis\nglobal COVID19 pandemic requires an international effort to understand the\ncomplexity of the disease and to develop innovative COVID-19 emergency and conventional\nvaccines\u201d, <\/em>said <strong>Dr.\nJan Groen CEO of Intravacc<\/strong>.<em> \u201cWe also need to establish partnerships with\npharma for large scale manufacturing and global distribution of these\nvaccines\u201d. <\/em><em><\/em><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">To develop safe and\neffective COVID-19 vaccines, Intravacc is focusing on emergency and\nconventional vaccines. Intravacc\u2019s emergency vaccine is designed to activate\ncytotoxic T-cell responses. This emergency vaccine would reduce&nbsp; mortality\nand morbidity and as a result reduces the pressure on the public health system.\nFor this vaccine Intravacc uses its outer membrane vesicle (OMV) technology. <\/p>\n\n\n\n<p class=\"wp-block-paragraph\">For its conventional\nCOVID-19 vaccine Intravacc will use OMV\u2019s&nbsp; as a carrier for spike proteins\nof the virus to induce a protective antibody response. For the third concept\nIntravacc\u2019s approved Vero cell platform will be used to develop an intranasal\nvector vaccine based on Newcastle disease virus, that can replicate in humans\nbut does not cause disease.&nbsp; <\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The expected development timelines for these COVID-19 vaccines to enter into phase 1 range from 9 to 21 months.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Source: <a href=\"https:\/\/www.intravacc.nl\/\"><strong>Intravacc (press release)<\/strong><\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Intravacc, one of the leading translational research and development vaccine institutes with an extensive track record in developing viral and bacterial&nbsp; vaccines,&nbsp; today announced the&nbsp; development of three COVID-19 vaccine concepts. These concepts are all based on Intravacc\u2019s platform technologies, that have been proven safe in humans. \u201cThis global COVID19 pandemic requires an international effort [&hellip;]<\/p>\n","protected":false},"author":6,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[39],"tags":[],"class_list":["post-17239","post","type-post","status-publish","format-standard","hentry","category-gezondheid"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.0 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Intravacc to develop emergency and conventional COVID-19 vaccines - hollandbio<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.hollandbio.nl\/en\/nieuws\/intravacc-to-develop-emergency-and-conventional-covid-19-vaccines\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Intravacc to develop emergency and conventional COVID-19 vaccines - hollandbio\" \/>\n<meta property=\"og:description\" content=\"Intravacc, one of the leading translational research and development vaccine institutes with an extensive track record in developing viral and bacterial&nbsp; vaccines,&nbsp; today announced the&nbsp; development of three COVID-19 vaccine concepts. These concepts are all based on Intravacc\u2019s platform technologies, that have been proven safe in humans. \u201cThis global COVID19 pandemic requires an international effort [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.hollandbio.nl\/en\/nieuws\/intravacc-to-develop-emergency-and-conventional-covid-19-vaccines\/\" \/>\n<meta property=\"og:site_name\" content=\"hollandbio\" \/>\n<meta property=\"article:published_time\" content=\"2020-05-14T12:58:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2020-05-19T13:00:11+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.hollandbio.nl\/wp-content\/uploads\/2025\/01\/hb-opengraph_illu.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"675\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"hollandbio\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@hollandbio\" \/>\n<meta name=\"twitter:site\" content=\"@hollandbio\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"hollandbio\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/nieuws\\\/intravacc-to-develop-emergency-and-conventional-covid-19-vaccines\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/nieuws\\\/intravacc-to-develop-emergency-and-conventional-covid-19-vaccines\\\/\"},\"author\":{\"name\":\"hollandbio\",\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/#\\\/schema\\\/person\\\/833d6a25b39946e61c6101af1fa96fbb\"},\"headline\":\"Intravacc to develop emergency and conventional COVID-19 vaccines\",\"datePublished\":\"2020-05-14T12:58:00+00:00\",\"dateModified\":\"2020-05-19T13:00:11+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/nieuws\\\/intravacc-to-develop-emergency-and-conventional-covid-19-vaccines\\\/\"},\"wordCount\":247,\"publisher\":{\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/#organization\"},\"articleSection\":[\"Gezondheid\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/nieuws\\\/intravacc-to-develop-emergency-and-conventional-covid-19-vaccines\\\/\",\"url\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/nieuws\\\/intravacc-to-develop-emergency-and-conventional-covid-19-vaccines\\\/\",\"name\":\"Intravacc to develop emergency and conventional COVID-19 vaccines - hollandbio\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/#website\"},\"datePublished\":\"2020-05-14T12:58:00+00:00\",\"dateModified\":\"2020-05-19T13:00:11+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/nieuws\\\/intravacc-to-develop-emergency-and-conventional-covid-19-vaccines\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/nieuws\\\/intravacc-to-develop-emergency-and-conventional-covid-19-vaccines\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/nieuws\\\/intravacc-to-develop-emergency-and-conventional-covid-19-vaccines\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Intravacc to develop emergency and conventional COVID-19 vaccines\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/\",\"name\":\"hollandbio\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/#organization\",\"name\":\"hollandbio\",\"url\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.hollandbio.nl\\\/wp-content\\\/uploads\\\/2023\\\/08\\\/HollandBIO_logo.svg\",\"contentUrl\":\"https:\\\/\\\/www.hollandbio.nl\\\/wp-content\\\/uploads\\\/2023\\\/08\\\/HollandBIO_logo.svg\",\"width\":218.664,\"height\":29.659,\"caption\":\"hollandbio\"},\"image\":{\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/x.com\\\/hollandbio\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/hollandbio\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/#\\\/schema\\\/person\\\/833d6a25b39946e61c6101af1fa96fbb\",\"name\":\"hollandbio\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Intravacc to develop emergency and conventional COVID-19 vaccines - hollandbio","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.hollandbio.nl\/en\/nieuws\/intravacc-to-develop-emergency-and-conventional-covid-19-vaccines\/","og_locale":"en_US","og_type":"article","og_title":"Intravacc to develop emergency and conventional COVID-19 vaccines - hollandbio","og_description":"Intravacc, one of the leading translational research and development vaccine institutes with an extensive track record in developing viral and bacterial&nbsp; vaccines,&nbsp; today announced the&nbsp; development of three COVID-19 vaccine concepts. These concepts are all based on Intravacc\u2019s platform technologies, that have been proven safe in humans. \u201cThis global COVID19 pandemic requires an international effort [&hellip;]","og_url":"https:\/\/www.hollandbio.nl\/en\/nieuws\/intravacc-to-develop-emergency-and-conventional-covid-19-vaccines\/","og_site_name":"hollandbio","article_published_time":"2020-05-14T12:58:00+00:00","article_modified_time":"2020-05-19T13:00:11+00:00","og_image":[{"width":1200,"height":675,"url":"https:\/\/www.hollandbio.nl\/wp-content\/uploads\/2025\/01\/hb-opengraph_illu.png","type":"image\/png"}],"author":"hollandbio","twitter_card":"summary_large_image","twitter_creator":"@hollandbio","twitter_site":"@hollandbio","twitter_misc":{"Written by":"hollandbio","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.hollandbio.nl\/en\/nieuws\/intravacc-to-develop-emergency-and-conventional-covid-19-vaccines\/#article","isPartOf":{"@id":"https:\/\/www.hollandbio.nl\/en\/nieuws\/intravacc-to-develop-emergency-and-conventional-covid-19-vaccines\/"},"author":{"name":"hollandbio","@id":"https:\/\/www.hollandbio.nl\/en\/#\/schema\/person\/833d6a25b39946e61c6101af1fa96fbb"},"headline":"Intravacc to develop emergency and conventional COVID-19 vaccines","datePublished":"2020-05-14T12:58:00+00:00","dateModified":"2020-05-19T13:00:11+00:00","mainEntityOfPage":{"@id":"https:\/\/www.hollandbio.nl\/en\/nieuws\/intravacc-to-develop-emergency-and-conventional-covid-19-vaccines\/"},"wordCount":247,"publisher":{"@id":"https:\/\/www.hollandbio.nl\/en\/#organization"},"articleSection":["Gezondheid"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.hollandbio.nl\/en\/nieuws\/intravacc-to-develop-emergency-and-conventional-covid-19-vaccines\/","url":"https:\/\/www.hollandbio.nl\/en\/nieuws\/intravacc-to-develop-emergency-and-conventional-covid-19-vaccines\/","name":"Intravacc to develop emergency and conventional COVID-19 vaccines - hollandbio","isPartOf":{"@id":"https:\/\/www.hollandbio.nl\/en\/#website"},"datePublished":"2020-05-14T12:58:00+00:00","dateModified":"2020-05-19T13:00:11+00:00","breadcrumb":{"@id":"https:\/\/www.hollandbio.nl\/en\/nieuws\/intravacc-to-develop-emergency-and-conventional-covid-19-vaccines\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.hollandbio.nl\/en\/nieuws\/intravacc-to-develop-emergency-and-conventional-covid-19-vaccines\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.hollandbio.nl\/en\/nieuws\/intravacc-to-develop-emergency-and-conventional-covid-19-vaccines\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.hollandbio.nl\/en\/"},{"@type":"ListItem","position":2,"name":"Intravacc to develop emergency and conventional COVID-19 vaccines"}]},{"@type":"WebSite","@id":"https:\/\/www.hollandbio.nl\/en\/#website","url":"https:\/\/www.hollandbio.nl\/en\/","name":"hollandbio","description":"","publisher":{"@id":"https:\/\/www.hollandbio.nl\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.hollandbio.nl\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.hollandbio.nl\/en\/#organization","name":"hollandbio","url":"https:\/\/www.hollandbio.nl\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.hollandbio.nl\/en\/#\/schema\/logo\/image\/","url":"https:\/\/www.hollandbio.nl\/wp-content\/uploads\/2023\/08\/HollandBIO_logo.svg","contentUrl":"https:\/\/www.hollandbio.nl\/wp-content\/uploads\/2023\/08\/HollandBIO_logo.svg","width":218.664,"height":29.659,"caption":"hollandbio"},"image":{"@id":"https:\/\/www.hollandbio.nl\/en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/hollandbio","https:\/\/www.linkedin.com\/company\/hollandbio\/"]},{"@type":"Person","@id":"https:\/\/www.hollandbio.nl\/en\/#\/schema\/person\/833d6a25b39946e61c6101af1fa96fbb","name":"hollandbio"}]}},"_links":{"self":[{"href":"https:\/\/www.hollandbio.nl\/en\/wp-json\/wp\/v2\/posts\/17239","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.hollandbio.nl\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.hollandbio.nl\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.hollandbio.nl\/en\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/www.hollandbio.nl\/en\/wp-json\/wp\/v2\/comments?post=17239"}],"version-history":[{"count":0,"href":"https:\/\/www.hollandbio.nl\/en\/wp-json\/wp\/v2\/posts\/17239\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.hollandbio.nl\/en\/wp-json\/wp\/v2\/media?parent=17239"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.hollandbio.nl\/en\/wp-json\/wp\/v2\/categories?post=17239"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.hollandbio.nl\/en\/wp-json\/wp\/v2\/tags?post=17239"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}